Compass Therapeutics, Inc. (CMPX)
1.815
-0.06
(-2.94%)
USD |
NASDAQ |
May 07, 16:00
1.80
-0.02
(-0.83%)
After-Hours: 06:00
Compass Therapeutics EPS Diluted (Quarterly) : -0.0983 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Organon & Co. | 0.5554 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Insmed, Inc. | -1.538 |
| Intellia Therapeutics, Inc. | -0.8263 |
| Definium Therapeutics, Inc. | -0.5106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.32M |
| Total Expenses (Quarterly) | 18.32M |
| Enterprise Value | 151.87M |
| Earnings Yield | -22.68% |
| Normalized Earnings Yield | -22.67 |